[exclusive] establish a unified platform for national drug bidding? Three tips for the truth

From yesterday to now, the pharmaceutical circle has been shaking for no other reason It is due to a notice on convening a symposium on the construction of national drug consumables bidding and purchasing platform Then, some pharmaceutical people are not calm They think that in the future, all drug bidding has gone to the national platform for bidding and purchasing, the unified price of national drugs has arrived, and the national drug information will be more transparent For this kind of argument, the author thinks that it is a typical linear thinking method In fact, the establishment of the national drug bidding unified platform is not so terrible as we expected In my opinion, this is actually just a routine action implemented after the establishment of the medical insurance bureau So, what is behind the establishment of the unified platform for national drug bidding and procurement? Let's see the relevant conjecture and analysis of the author 1、 Positioning differences between "national mining platform" and "national management platform" In October 2014, the statistical information center of the national health and Family Planning Commission and the drug administration department jointly issued the notice on the pilot work of the construction of the comprehensive management information system of the national drug supply guarantee The original intention of the notice is not complicated It is to connect the provincial drug procurement platform and the national drug management platform, standardize the construction, unify the drug coding, etc., so as to realize the centralized drug procurement data in China Exchange and sharing of home and provincial platforms Including drug bidding, procurement, distribution and settlement The original intention at that time also had a certain vision, that is, "the national drug control platform is an information platform After docking with the provincial drug centralized procurement center, the future national classified procurement, national drug price negotiation mechanism and other negotiation prices will be publicized on this platform." It is not difficult to see that the positioning of the national management platform is the "data management control" platform of "no bidding, no procurement" The biggest impact on pharmaceutical enterprises is that the procurement (bid winning) prices all over the country are reflected in the national management platform, which has the basic role of data comparison and analysis for the provinces to carry out bidding procurement The positioning of Guocai platform should be based on the Guoguan platform or part of Guoguan platform, and under the premise of strengthening basic data management, the comprehensive platform of "combination of bidding and procurement" If the platform is built successfully, it will be an effective "grab" and "sharp tool" for drug price management after the establishment of the medical insurance bureau The positioning of Guoguan platform and Guocai platform is not the same, and the organizers of the two platforms are not the same (some words can only be pointed out to the end, but can not be said) Therefore, in the context of the establishment of the Medical Insurance Bureau under the situation, the establishment of Guocai platform is not surprising 2、 4 + 7 project is the main reason for the establishment of Guocai platform From November 15, 2018, 4 + 7 officially announced the procurement documents, and then to December 17, 2018, the results of the selection were published In one month, the speed was not too fast, but by March 5, 2019, the progress of 4 + 7 in the pilot cities was still in the "steady progress" stage Some pilot cities have to go through such procedures as online publicity, publication, submission of materials, qualification review, and publication of procurement opinions One quarter has passed in 2019, and "comprehensive promotion" is the degree of promotion It is better to centralize the operation of the procurement platform than to make the procurement platform in a decentralized implementation situation and to organize drug price reduction procurement by "laying eggs on the back of chickens" In fact, this idea is not ybJ's unique way As early as the end of November 2014, the relevant departments of the national health and Family Planning Commission had proposed the idea of establishing a national drug negotiation mechanism, proposed to establish a unified national drug procurement platform, and participated in national negotiations on patent and exclusive drug implementation At the end of that year, some relevant departments considered to propose "actively explore the gradual integration of drug procurement into the national unified resource exchange platform, open and transparent, implement bad records, and investigate and punish violations of laws and regulations" In other words, Guocai platform only needs to complete the unfinished work of management platform 3、 In the future, the number of Guocai platforms is expected to achieve national unification and give full play to national drug procurement If there is such a big brain opening idea, it is just wishful thinking Taking GPO in Guangzhou as an example, the drug purchasing departments in each district and city have been busy in the morning and night Therefore, it is a small probability for Guocai platform to achieve the unification of purchasing in the future, but it is a large probability to achieve the unification of data interaction So, how many varieties will be the most suitable for the future procurement platform? At present, the positioning of Guocai platform should be to assist the implementation of the second and third batches of 4 + 7 projects So, how many kinds of bidding procurement will there be for Guocai platform in the future? According to a popular saying in the early stage of internal business, the next step of 4 + 7 procurement is to purchase 80% of the amount of drugs, about 200-300 varieties, in three rounds Therefore, the completion of these varieties basically means that the focus has been caught, and the rest varieties are still carried out by all regions (public bidding + direct networking + GPO + regional price linkage + special procurement regional alliance) But after the establishment of Guocai platform, is it going smoothly? Although the purchasing function has been given to the medical insurance bureau, the real purchaser - the medical institution still belongs to the health care Commission How to seamlessly link the two for effective combination of policy promotion and implementation remains to be seen Statement: this opinion only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.